SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 91 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $24,000 | -85.9% | 200,000 | +100.0% | 0.00% | -100.0% |
| Q3 2018 | $170,000 | -2.3% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $174,000 | -39.8% | 100,000 | +61.0% | 0.00% | 0.0% |
| Q1 2017 | $289,000 | -8.5% | 62,106 | +19.8% | 0.00% | -33.3% |
| Q4 2016 | $316,000 | -27.0% | 51,839 | -34.0% | 0.01% | -14.3% |
| Q3 2016 | $433,000 | -60.6% | 78,577 | -80.3% | 0.01% | -61.1% |
| Q1 2016 | $1,098,000 | -71.3% | 398,228 | -41.1% | 0.02% | -37.9% |
| Q4 2015 | $3,832,000 | +114.0% | 676,028 | +100.0% | 0.03% | +3.6% |
| Q3 2015 | $1,791,000 | +79.6% | 338,014 | +38.0% | 0.03% | +133.3% |
| Q2 2014 | $997,000 | +1115.9% | 244,884 | +1259.6% | 0.01% | +1100.0% |
| Q3 2013 | $82,000 | – | 18,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |